NeuroSigma.png
NeuroSigma Announces Promotion of Dr. Colin Kealey to President
January 11, 2022 11:00 ET | NeuroSigma, Inc.
LOS ANGELES, Jan. 11, 2022 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a bioelectronic medical device company, today announced the promotion of Dr. Colin Kealey to President. NeuroSigma is the developer...
QBioMed-Logo_Final.png
Q BioMed, Inc. CEO Discusses Recently Announced International Market Authorizations and Expansion in to South and Central America and Asia for Q BioMed’s Strontium89, its FDA Approved Drug for the Non-Opioid Treatment of Metastatic Cancer in the Bone
September 22, 2020 07:00 ET | Q BioMed Inc.
AUSTIN, Texas, Sept. 22, 2020 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (“SCV”) today announces the availability of a new interview with Q BioMed Inc. (“the Company”) (OTCQB: QBIO), a commercial...
QBioMed-Logo_Final.png
Q BioMed, Inc. CEO Discusses Recently Announced Global Distribution Partnership with Caligor Coghlan Pharma Services in Audio Interview with SmallCapVoice.com
July 09, 2020 08:00 ET | Q BioMed Inc.
AUSTIN, Texas, July 09, 2020 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (“SCV”) today announces the availability of a new interview with Q BioMed Inc. (“the Company”) (OTCQB: QBIO), a commercial...
OmniPathology-Logo-Color-01.jpg
OmniPathology Receives FDA Emergency Use Authorization for New Omni-COVID-19 Molecular Test
June 22, 2020 08:45 ET | OmniPathology
PASADENA, Calif., June 22, 2020 (GLOBE NEWSWIRE) -- OmniPathology today announced that it has received an FDA Emergency Use Authorization EUA letter for its Omni-COVID-19 Assay polymerase chain...
QBioMed-Logo_Final.png
Denis Corin, CEO, of Q BioMed Inc. Provides Key Updates and Outlook in a New Audio Interview with SmallCapVoice.com
April 30, 2020 08:00 ET | Q BioMed Inc.
NEW YORK, April 30, 2020 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (SCV) and Q BioMed Inc. (OTCQB: QBIO) (the "Company"), a commercial stage biotechnology company, announced today that a new audio...
Behold-Logo-RGB-Dark.jpg
US FDA clears behold.ai’s AI algorithm for radiology triage
March 12, 2020 08:00 ET | Behold.ai Technologies Limited
US FDA clears behold.ai’s AI algorithm for radiology triage LONDON March 12, 2020 – The US Food and Drug Administration (FDA) has cleared the use of behold.ai’s red dot® algorithm for ‘instant...
60483_BioElectronis.jpg
BioElectronics Announces FDA Market Clearance for Its Non-Opioid Postoperative Pain Therapy
July 01, 2019 08:57 ET | BioElectronics Corporation
FREDERICK, MD, July 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com, the maker of non-invasive electroceutical devices, is pleased to...
Cohera Medical, Inc.® Receives FDA Approval to Begin Clinical Trials of its Sylys® Surgical Sealant in the U.S.
July 12, 2016 09:30 ET | Cohera Medical, Inc.
RALEIGH, N.C., July 12, 2016 (GLOBE NEWSWIRE) -- Cohera Medical, Inc., a leading innovator and developer of absorbable surgical adhesives and sealants, today announced that it has received...
Medical Device Helps Audiologists Improve Hearing Aid Performance, Increase Patient Satisfaction
September 18, 2012 10:53 ET | Now Hear This
RALEIGH, N.C., Sept. 18, 2012 (GLOBE NEWSWIRE) -- An audiologist at the practice, Now Hear This is the first in the US to use a device that greatly improves the performance of hearing aids, an...
TAGI Pharma Announces Exclusive Marketing Rights Agreement for Codeine Sulfate Oral Solution CII, 30MG/5ML
April 10, 2012 08:30 ET | TAGI Pharma, Inc.
SOUTH BELOIT, Ill., April 10, 2012 (GLOBE NEWSWIRE) -- TAGI Pharma, Inc., a subsidiary of Precision Dose, Inc., announced today the signing of an exclusive marketing rights agreement to market and...